Therapeutic Options for Sleep‐Maintenance and Sleep‐Onset Insomnia
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Insomnia, defined as difficulty falling asleep, staying asleep, and/or experiencing restorative sleep with associated impairment or significant distress, is a common condition resulting in significant clinical and economic consequences. Many options are available to treat insomnia, to assist with either falling asleep (sleep onset) or maintaining sleep. We searched MEDLINE for articles published between January 1996 and January 2006, evaluated abstracts from recent professional meetings, and contacted the manufacturer of the most recent addition to the pharmacologic armamentarium for insomnia treatment (ramelteon) to gather information. Nonpharmacologic options include stimulus control, sleep hygiene education, sleep restriction, paradoxical intention, relaxation therapy, biofeedback, and cognitive behavioral therapy. Prescription and over‐the‐counter drug therapies include benzodiazepine and nonbenzodiazepine sedative‐hypnotic agents; ramelteon, a melatonin receptor agonist; trazodone; and sedating antihistamines. Herbal and alternative preparations include melatonin and valerian. Before recommending any treatment, clinicians should consider patient‐specific criteria such as age, medical history, and other drug use, as well as the underlying cause of the sleep disturbance. All pharmacotherapy should be used with appropriate caution, at minimum effective doses, and for minimum duration of time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Behavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial
Morin, C. M., Colecchi, C., Stone, J., Sood, R., & Brink, D. (1999) · JAMA · doi:10.1001/jama.281.11.991 · Cited by 1,095
Insomnia and Its Treatment: Prevalence and Correlates
Mellinger, G. D. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790260019002 · Cited by 1,071
McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience · doi:10.1038/75761 · Cited by 944
Nonpharmacologic Treatment of Chronic Insomnia
Morin, C. M., Hauri, P. J., Espie, C. A., Spielman, A. J., Buysse, D. J., & Bootzin, R. R. (1999) · Sleep · doi:10.1093/sleep/22.8.1134 · Cited by 888
Comparative Meta-Analysis of Pharmacotherapy and Behavior Therapy for Persistent Insomnia
Smith, M. T., Perlis, M. L., Park, A., Smith, M. S., Pennington, J., Giles, D. E., & Buysse, D. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.5 · Cited by 863
Use of sleep hygiene in the treatment of insomnia
Stepanski, E. J., & Wyatt, J. K. (2003) · Sleep Medicine Reviews · doi:10.1053/smrv.2001.0246 · Cited by 733
Prevalence, burden, and treatment of insomnia in primary care
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.10.1417 · Cited by 694
Krystal, A. D., Walsh, J. K., Laska, E., Caron, J., Amato, D. A., Wessel, T. C., & Roth, T. (2003) · Sleep · doi:10.1093/sleep/26.7.793 · Cited by 630
Edinger, J. D., Wohlgemuth, W. K., Radtke, R. A., Marsh, G. R., & Quillian, R. E. (2001) · JAMA · doi:10.1001/jama.285.14.1856 · Cited by 625
Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.17.1888 · Cited by 579
Effects of exogenous melatonin on sleep: a meta-analysis
Brzezinski, A., Vangel, M. G., Wurtman, R. J., Norrie, G., Zhdanova, I., Ben-Shushan, A., & Ford, I. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.06.004 · Cited by 541 · cited 2×
“There are no trials comparing melatonin with prescription hypnotics in short-term or chronic insomnia.(116)”
BackgroundMedical and socio-professional impact of insomnia
Léger, D., Guilleminault, C., Bader, G., Lévy, E., & Paillard, M. (2002) · Sleep · doi:10.1093/sleep/25.6.621 · Cited by 468
Benzodiazepines and Zolpidem for Chronic Insomnia: A Meta-analysis of Treatment Efficacy
Nowell, P. D. (1997) · JAMA · doi:10.1001/jama.1997.03550240060035 · Cited by 451
A Review of the Evidence for the Efficacy and Safety of Trazodone in Insomnia
Mendelson, W. B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0409 · Cited by 308
Melatonin treatment for age-related insomnia
Zhdanova, I. V., Wurtman, R. J., Regan, M. M., Taylor, J. A., Shi, J. P., & Leclair, O. U. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7901 · Cited by 308
Practice Parameters for the Nonpharmacologic Treatment of Chronic Insomnia
Chesson, A. L., Anderson, W. M., Littner, M., Davila, D., Hartse, K., Johnson, S., Wise, M., & Rafecas, J. (1999) · Sleep · doi:10.1093/sleep/22.8.1128 · Cited by 264
A systematic review of non-pharmacological therapies for sleep problems in later life
Montgomery, P. (2004) · Sleep Medicine Reviews · doi:10.1016/s1087-0792(03)00026-1 · Cited by 260
ROTH, T., WALSH, J., KRYSTAL, A., WESSEL, T., & ROEHRS, T. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2005.06.004 · Cited by 230 · cited 1×
“0001 for all monthly end points).(91) The significant improvements in sleep and daytime function were also sustained during the 6 months of open-label treatment for those who had received eszopiclone during the double-blind study.”
BackgroundSleep disturbances and mood disorders: An epidemiologic perspective
Ford, D. E., & Cooper-Patrick, L. (2001) · Depression and Anxiety · doi:10.1002/da.1041 · Cited by 202
Eight Weeks of Non-Nightly Use of Zolpidem for Primary Insomnia
Walsh, J. K., Roth, T., Randazzo, A., Erman, M., Jamieson, A., Scharf, M., Schweitzer, P. K., & Ware, J. C. (2000) · Sleep · doi:10.1093/sleep/23.8.1h · Cited by 158
Trazodone enhances sleep in subjective quality but not in objective duration
Montgomery, I., Oswald, I., Morgan, K., & Adam, K. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb04977.x · Cited by 145
Mendelson, W. (2004) · Sleep Medicine Reviews · doi:10.1016/s1087-0792(03)00042-x · Cited by 142
Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines
Kales, A., Manfredi, R. L., Vgontzas, A. N., Bixler, E. O., Vela-Bueno, A., & Fee, E. C. (1991) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1991.55 · Cited by 90
Hajak, G., Cluydts, R., Declerck, A., Estivill, S. E., Middleton, A., Sonka, K., & Unden, M. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200201000-00002 · Cited by 77
Cited by
Review of Safety and Efficacy of Sleep Medicines in Older Adults
Schroeck, J. L., Ford, J., Conway, E. L., Kurtzhalts, K. E., Gee, M. E., Vollmer, K. A., & Mergenhagen, K. A. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.09.010 · Cited by 373
Boivin, D. B., Tremblay, G. M., & James, F. O. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.03.015 · Cited by 214
Chronobiological aspects of nutrition, metabolic syndrome and obesity
Garaulet, M., & Madrid, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.05.005 · Cited by 177
“However, their efficacy has been counteracted by important side effects [97] and so new drugs have been developed, which act on the machinery of the clock rather than simply sedating the person, thus improving sleep and causing fewer secondary effects.”
BackgroundVeauthier, C., Hasselmann, H., Gold, S. M., & Paul, F. (2016) · EPMA Journal · doi:10.1186/s13167-016-0073-3 · Cited by 71
Metadata
- Authors
- Morin, A. K., Jarvis, C. I., & Lynch, A. M.
- Venue
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Publisher
- Wiley
- Published
- 2007-01
- Volume
- 27
- Issue
- 1
- Pages
- 89-110
- ISSN
- 0277-0008 (ISSN-L)
- 1875-9114
- OpenAlex
- W2120033951
- Cited by
- 122
- References
- 25
- FWCI
- 13.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.